Tenofovir therapy is associated with increased urinary phosphate excretion and decreased bone mineral density in patients with chronic hepatitis B

被引:0
|
作者
Le, S. [1 ,2 ]
Wong, P. [3 ,4 ,5 ]
Shochet, I. [6 ]
Doyle, A. [1 ]
Shelton, E. [1 ]
Milat, F. [3 ,4 ,5 ]
Sievert, W. [1 ,2 ]
机构
[1] Monash Hlth, Dept Gastroenterol & Hepatol, Clayton, Vic 3168, Australia
[2] Monash Univ, Ctr Inflammatory Dis, Clayton, Vic 3168, Australia
[3] Prince Henrys Inst Med Res, Clayton, Vic 3168, Australia
[4] Monash Hlth, Dept Endocrinol, Clayton, Vic 3168, Australia
[5] Monash Univ, Dept Med, Southern Clin Sch, Clayton, Vic 3168, Australia
[6] Monash Hlth, Dept Gen Med, Clayton, Vic 3168, Australia
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:161 / 161
页数:1
相关论文
共 50 条
  • [1] Decreased bone mineral density in noncirrhotic patients with chronic hepatitis B or C
    Schiefke, I
    Borte, G
    Wiese, M
    Schenker, E
    Fach, A
    JOURNAL OF HEPATOLOGY, 2002, 36 : 106 - 106
  • [2] BONE MINERAL DENSITY LOSS IN TENOFOVIR TREATED CHRONIC HEPATITIS B VIRUS (HBV) PATIENTS IS A CONSEQUENCE OF VITAMIN D DEFICIENCY AND NOT TENOFOVIR THERAPY
    Gill, U. S.
    Al-Shamma, S.
    Burke, K.
    Ross, V.
    Marley, R. T. C.
    Kooner, P.
    Foster, G. R.
    Kennedy, P. T. F.
    GUT, 2011, 60 : A28 - A28
  • [3] BONE MINERAL DENSITY LOSS IN TENOFOVIR TREATED CHRONIC HEPATITIS B VIRUS (HBV) PATIENTS IS A CONSEQUENCE OF VITAMIN D DEFICIENCY AND NOT TENOFOVIR THERAPY
    Gill, Upkar
    Al-shamma, Safa
    Burke, Katherine B.
    Ross, Valerie A.
    Marley, Richard
    Kooner, Paul
    Foster, Graham R.
    Kennedy, Patrick T.
    HEPATOLOGY, 2011, 54 : 1012A - 1012A
  • [4] FRAX SCORE IN THE ASSESSMENT OF BONE MINERAL DENSITY CHANGES IN TENOFOVIR TREATED CHRONIC HEPATITIS B PATIENTS
    Gill, U. S.
    Zissimopoulos, A.
    Al-shamma, S.
    Burke, K.
    McPhail, M.
    Barr, D.
    Ross, V.
    Kallis, Y.
    Kooner, P.
    Marley, R.
    Foster, G. R.
    Kennedy, P. T.
    GUT, 2013, 62 : A190 - A190
  • [5] Effects of Long-Term Tenofovir and Entecavir Treatment on Bone Mineral Density in Patients with Chronic Hepatitis B
    Kahraman, Resul
    Sahin, Abdurrahman
    Ozturk, Oguzhan
    Calhan, Turan
    Sayar, Suleyman
    Kanat, Evren
    Doganay, Levent
    Ozdil, Kamil
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2022, 33 (01): : 35 - 43
  • [6] Increased spine bone density in patients with chronic hepatitis B switched to tenofovir alafenamide: A prospective, multinational study
    Ogawa, Eiichi
    Jun, Dae Won
    Toyoda, Hidenori
    Hsu, Yao-Chun
    Yoon, Eileen L.
    Ahn, Sang Bong
    Yeh, Ming-Lun
    Do, Son
    Trinh, Huy N.
    Takahashi, Hirokazu
    Enomoto, Masaru
    Kawada, Norifumi
    Yasuda, Satoshi
    Tseng, Cheng-Hao
    Kawashima, Keigo
    Lee, Han Ah
    Inoue, Kaori
    Haga, Hiroaki
    Do, Ai-Thien
    Maeda, Mayumi
    Hoang, Joseph H.
    Cheung, Ramsey
    Ueno, Yoshiyuki
    Eguchi, Yuichiro
    Furusyo, Norihiro
    Yu, Ming-Lung
    Tanaka, Yasuhito
    Nguyen, Mindie H.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 59 (02) : 239 - 248
  • [7] FACTORS DETERMINING BONE MINERAL DENSITY LOSS IN CHRONIC HEPATITIS B PATIENTS: IS TENOFOVIR DISOPROXIL FUMARATE THE MAIN CULPRIT?
    Gill, U. S.
    Al-Shamma, S.
    Burke, K.
    Ross, V.
    Kooner, P.
    Marley, R.
    Foster, G. R.
    Kennedy, P. T. F.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S286 - S286
  • [8] FACTORS DETERMINING BONE MINERAL DENSITY LOSS IN CHRONIC HEPATITIS B PATIENTS: IS TENOFOVIR DISOPROXIL FUMARATE THE MAIN CULPRIT?
    Gill, U. S.
    Al-Shamma, S.
    Burke, K.
    Ross, V.
    Marley, R.
    Kooner, P.
    Foster, G. R.
    Kennedy, P. T. F.
    GUT, 2011, 60
  • [9] Areal Bone Mineral Density in Pediatric Patients with Chronic Hepatitis B or Chronic Hepatitis C
    Stefano Mora
    Vania Giacomet
    Alessandra Viganò
    Katia Maruca
    Silvia Capelli
    Pilar Nannini
    Gian Vincenzo Zuccotti
    Calcified Tissue International, 2014, 95 : 218 - 221
  • [10] Areal Bone Mineral Density in Pediatric Patients with Chronic Hepatitis B or Chronic Hepatitis C
    Mora, Stefano
    Giacomet, Vania
    Vigano, Alessandra
    Maruca, Katia
    Capelli, Silvia
    Nannini, Pilar
    Zuccotti, Gian Vincenzo
    CALCIFIED TISSUE INTERNATIONAL, 2014, 95 (03) : 218 - 221